Shares rose Thursday after results showed Pfizer announced positive results Wednesday for an early-stage vaccination trial. Pfizer said that patients created 1.8 to 2.8 times the antibodies seen in those who recovered from COVID-19. A market analyst said that the “V-shaped recovery gnomes, once again, are getting to heaven.” But …
Read More »
Text size Daniel Acker / Bloomberg Shares of the large pharmaceutical company Pfizer continue to rise one day after the company revealed promising and detailed data on a trial of its experimental vaccine Covid-19. Analysts said the highly aggressive timeline the company outlined on Wednesday was exciting, but far from …
Read More »
In the month ending April 7, 423 cancer patients at Memorial Sloan Kettering Cancer Center were diagnosed with COVID-19, 20% of whom developed severe respiratory symptoms. That in itself was not surprising, given that cancer patients are immunocompromised and therefore face an increased risk of fighting the virus. But a …
Read More »